Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

被引：9
|
作者：
Nagel, Sylke [3 ]
Califano, Raffaele [2 ]
Thatcher, Nicholas [1 ]
Blackhall, Fiona [1 ]
机构：
[1] Christie Hosp, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[2] Osped Santa Maria Misericordia, SC Oncol Med, I-06120 Perugia, Italy
[3] Martha Maria Hosp, D-06120 Halle, Germany
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷 / 18期
关键词：
carboplatin; chemotherapy; gemcitabine; non-small-cell lung cancer;
D O I：
10.1517/14656566.8.18.3265
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The universally accepted first-line treatment for advanced (stage IIIB effusion/IV) non-small-cell lung cancer in patients with a good performance status is a platinum drug in combination with one of gemcitabine, paclitaxel, vinorelbine or docetaxel. Although cisplatin is generally the favoured platinum agent, gemcitabine partnered with carboplatin is convenient to administer and has a favourable toxicity profile. Here, the pharmacology, preclinical and clinical data to support the use of this regimen for the treatment of advanced non-small-cell lung cancer is evaluated.
引用
收藏
页码：3265 / 3275
页数：11
相关论文
共 50 条
  • [41] Comparison of gemcitabine-carboplatin and oral vinorelbine-carboplatin in patients with advanced non-small cell lung cancer
    Mitchell, C.
    Sivaramalingam, M.
    Hindley, A.
    Lau, S.
    LUNG CANCER, 2012, 75 : S8 - S8
  • [42] Gemcitabine and vinorelbine in advanced non-small cell lung cancer
    Vazquez, F
    Cueva, JF
    Baron, FJ
    Candamio, S
    Calvo, M
    Irigoyen, A
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [43] Comparison of quality of life of patients on treatment with cisplatin and gemcitabine, carboplatin and gemcitabine, carboplatin and paclitaxel, carboplatin and pemetrexed for non-small cell lung cancer
    Saranya, K.
    Sreejith, K.
    Ajaykumar
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 1853 - 1859
  • [44] A novel dosing schedule with gemcitabine, vinorelbine, and carboplatin for advanced non-small cell cancer of the lung.
    Sadasivan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 708S - 708S
  • [45] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [46] A phase I study of gemcitabine and carboplatin in non-small cell lung cancer
    Carmichael, J
    Allerheiligen, S
    Walling, J
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 55 - 59
  • [47] Biweekly combination chemotherapy with paclitaxel and carboplatin for advanced non-small cell lung cancer.
    Takayama, K
    Ichiki, M
    Kawasaki, M
    Ninomiya, K
    Miyazaki, N
    Kuba, M
    Iwami, F
    Nakanishi, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 699S - 699S
  • [48] Retrospective analysis of administration of a combination of docetaxel and carboplatin for advanced non-small cell lung cancer
    Bando, H
    Miyata, J
    Sano, T
    Sumitomo, M
    ANTICANCER RESEARCH, 2001, 21 (3C) : 2107 - 2113
  • [49] Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma
    Gajra, A
    Mehdi, SA
    Kirshner, J
    Newman, N
    Graziano, SL
    LUNG CANCER, 2001, 32 (02) : 189 - 196
  • [50] Carboplatin plus gemcitabine followed by weekly paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
    Tjan-Heijnen, V
    Timmer-Bonte, J
    van der Drift, M
    van Leeuwen, F
    de Boo, T
    Wagenaar, M
    van Die, L
    Bussink, J
    LUNG CANCER, 2005, 49 : S272 - S272
12345